The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances

Journal of Alzheimer's Disease

Volumn 18, Issue 1, 2009, Pages 125-130

  Albani, Diego ^a   Prato, Francesca ^a   Tettamanti, Mauro ^a   Lovati, Carlo ^b   Galimberti, Daniela ^d   Restelli, Ilaria ^d   Mariani, Claudio ^b   Quadri, Pier Luigi ^c   Scarpini, Elio ^d   Lucca, Ugo ^a   Forloni, Gianluigi ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedali Regionali of Mendrisio and Lugano   (Switzerland)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

5 HTTLPR; Alzheimer's disease; Behavioral and psychological symptoms of dementia (BPSD); Genetics; Rs25531; Serotonin; Serotonin transporter

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODULATION TRANSFER FUNCTION; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOLOGICAL RATING SCALE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

EID: 70349151294     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1129     Document Type: Article

References (31)

1. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunet-ti N, Dalmonte E, Bianchin M, Mariani E (2005) Incidence and etiology of dementia in a large elderly Italian population. Neurology 64, 1525-1530.
2. Pastor P, Goate AM (2004) Molecular genetics of Alzheimer's disease. Curr Psychiatry Rep 6, 125-133.
3. Rocchi A, Pellegrini S, Siciliano G, Murri L (2003) Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 61, 1-24.
4. Serretti A, Artioli P, Quartesan R, De Ronchi D (2005) Genes involved in Alzheimer's disease, a survey of possible candidates. J Alzheimers Dis 7, 331-353.
5. Ropacki SA, Jeste DV (2005) Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry 162, 2022-2030.
6. Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nim-gaonkar VL, Sweet RA (2005) Heritability of psychosis in Alzheimer disease. Am J Geriatr Psychiatry 13, 624-627.
7. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P (1994) Organization of the human serotonin transporter gene. J Neural Transm 95, 157-162.
8. Nakamura M, Ueno S, Sano A, Tanabe H (2000) The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5, 32-38.
9. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D,̈ Lesch P (1996) Allelic variation of human serotonin trasporter gene expression. J Neurochem 66, 2621-2624.
10. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL (1999) Association of the sero-tonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry 4, 463-466.
11. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with apolymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
12. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1, 453-460.
13. Li T, Holmes C, Sham PC, Vallada H, Birkett J, Kirov G, Lesch KP, Powell J, Lovestone S, Collier D (1997) Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport 8, 683-686.
14. Sweet RA, Pollock BG, Sukonick DL, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE (2001) The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int Psychogeriatr 13, 401-409.
15. Rocchi A, Micheli D, Ceravolo R, Manca ML, Tognoni G, Siciliano G, Murri L (2003) Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. Genet Test 7, 309-314.
16. Assal F, Alarcon M, Solomon EC, Masterman D, Geschwind́ DH, Cummings JL (2004) Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol 61, 1249-1253.
17. Ha TM, Cho DM, Park SW, Joo MJ, Lee BJ, Kong BG, Kim JM, Yoon JS, Kim YH (2005) Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients. Dement Geriatr Cogn Disord 20, 31-34.
18. Borroni B, Grassi M, Agosti C, Costanzi C, Archetti S, Fran-zoni S, Caltagirone C, Di Luca M, Caimi L, Padovani A (2006) Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging 27, 1595-1603.
19. Pritchard AL, Pritchard CW, Bentham P, Lendon CL (2007) Role of serotonin transporter polymorphisms in the be-havioural and psychological symptoms in probable Alzheimer disease patients. Dement Geriatr Cogn Disord 24, 201-206.
20. Ueki A, Ueno H, Sato N, Shinjo H, Morita Y (2007) Sero-tonin transporter gene polymorphism and BPSD in mild Alzheimer's disease. J Alzheimers Dis 12, 245-253.
21. Grunblatt E, Zehetmayer S, Bartl J, L̈ offler C, Wichart I, Rainer̈ MK, Jungwirth S, Bauer P, Danielczyk W, Tragl KH, Rieder-er P, Fischer P (2009) Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J Psychiatr Res 43, 298-308.
22. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL (2006) Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11, 224-226.
23. Borroni B, Grassi M, Agosti C, Archetti S, Costanzi C, Cornali C, Caltagirone C, Caimi L, Di Luca M, Padovani A (2006) Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease. Am J Geriatr Psychiatry 14, 343-351.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
25. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32, 632-637.
26. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
27. Lucca U, Tettamanti M, Martelli P, Lucchelli F, Alberoni M (1996) Spontaneous Behaviour Interview: from test performance to daily life-based Alzheimer patient evaluation [Abstract]. The challenge of the dementias. Edinburgh, UK: The Lancet.
28. Lucca U, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A, Tallone MV, Detoma P, Giacomin A, Clerico M, Tempia P, Guala A, Fasolo G, Riva E (2008) Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the "Health and Anemia" study. PLoS ONE 3:e1920.
29. Lucca U, Tettamanti M (2000) Clinical course of Alzheimer's disease and strategies to assess the therapeutic intervention (Italian). In Recenti progressi sulla malattia di Alzheimer, Muller EE ed. Pythagora Press, Milan, pp. 71-78.
30. Davidson RJ, Putnam KM, Larson CL (2000) Dysfunction in the neural circuitry of emotion regulation - a possible prelude to violence. Science 289, 591-594.
31. Bhana N, Spencer CM (2000) Risperidone: A review of its use in the management of the behavioral and psychological symptoms of dementia. Drugs Aging 16, 451-471.